Moon helps Rady Children's Hospital in San Diego to establish new world record

Dr. Stephen Kingsmore and his team at Rady Children’s Institute for Genomic medicine just proved it’s possible to diagnose a rare disease patient based on whole genome sequencing in just 19.5 hours. Our Moon software has been used to provide clinical interpretation of the WGS data in just 4 minutes. Read the full story

Share:


Experience Moon at the Festival of Genomics


Diploid is delighted to be attending the Festival of Genomics in London, January 30 – 31. Come by our booth LP21 to witness how Moon diagnoses a rare disease patient in just two minutes.

Share:


Moon being discussed by enlightenbio

Brigitte Ganter from enlightenbio has written an interesting blog post about Diploid in general, and about our Moon software in particular.

Share:


Moon autonomously diagnoses rare diseases within minutes

We're excited to announce the launch of Moon, the world's first software to autonomously diagnose rare diseases. More patients are suffering from rare diseases than from AIDS and cancer combined. For many of these patients, it takes months or even years before they reach a correct diagnosis. Moon allows genetic centres to diagnose patients in minutes, instead of days or weeks. Read the press release, or visit the Moon homepage.

Share:


Diploid introduces Diagnosed

Today we introduced Diagnosed, a service that pinpoints the molecular cause of rare diseases. Diagnosed is based on WGS and includes SNP and CNV analysis.
Do you have patients that are undiagnosed even though they have been whole genome sequenced? Then Diagnosed could provide the answer. If we can't, we will refund the cost of the analysis. Read more at http://www.diploid.com/diagnosed.

Share:


We're hiring a Clinical Geneticist

Join our team to work on groundbreaking projects in the field of human genome interpretation. More information is available at http://www.diploid.com/jobs/clinical-geneticist-40. Feel free to share this job position with colleagues and friends using the share buttons below.

Share:


Sengenics and Diploid Sign Exclusive Partnership

We're excited to announce that Diploid has just signed an exclusive partnership with Sengenics to enable more streamlined NGS diagnostics in the Middle East and GCC countries. We are honoured that from now on, Sengenics will be working exclusively with Diploid for the interpretation of all their WES and WGS samples. We're looking forward to providing a diagnosis for more patients, faster. The full press release is available at http://www.diploid.com/press/diploid-sengenics

Share: